AuntMinnie

APRIL 12, 2023

PET/CT imaging surpasses bone scintigraphy for detecting bone metastases i.

Bone Scintigraphy 130

Bone Scintigraphy MRI Imaging 130

AuntMinnie

NOVEMBER 15, 2023

Still, PET imaging in breast cancer may be among this year’s hottest topics, with studies suggesting FDG-PET/MRI may be reliable in newly diagnosed patients and another revealing which potential tracer is more effective in women with metastatic lesions, namely F-18 fluciclovine or Ga-68 PSMA. Monday, November 27 | 8:30 a.m.-8:40 8:40 a.m. |

Bone Scintigraphy 290

Bone Scintigraphy Imaging Nuclear Medicine MRI 290

AuntMinnie

FEBRUARY 26, 2025

FDG-PET/CT provides functional insights by detecting metabolic changes before structural alterations, making it valuable for therapy response monitoring, but it has limitations in visualizing metabolically silent bone metastases, according to Masperi and Girlando. Scans were conducted using two CT systems (Somatom go.Top from Siemens).

Bone Scan 130

Bone Scan Radiopharmaceuticals Imaging Modalities Bone Scintigraphy 130

AuntMinnie

MAY 31, 2023

PET/CT is more accurate than bone scintigraphy for detecting bone metastase. PET/CT key to imaging patients with prostate cancer PET tracer for prostate cancer performs well in phase III trial PSMA-PET matches MRI, beats CT in diagnosing liver cancer PET tracer may improve prostate cancer imaging

Bone Scintigraphy 130

Bone Scintigraphy Diagnose MRI Imaging 130